ArticleCancer research2006

Antibody-maytansinoid conjugates are activated in targeted cancer cells by lysosomal degradation and linker-dependent intracellular processing.

Hans K Erickson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.